Severe Acute Hepatitis B Treated with Entecavir

Severe Acute Hepatitis B Treated with Entecavir

Show other versions (1)

Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. We present here a case of a 62-year-old man affected by severe acute hepatitis B with progressive worsening of clinical an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Giuseppe Vittorio Luigi De Socio, Alessio Sgrelli, Andrea Tosti, Franco Baldelli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2011-03-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Acute Hepatitis B, Entecavir, HBV therapy
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/316
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01)

Experience of entecavir therapy in chronic hepatitis B
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01)

Adherence to entecavir for chronic hepatitis B and correlation with effectiveness
by: Vanessa Romero Díaz-Maroto, et al.
Published: (2015-11-01)

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B
by: Takuya Matsubara, et al.
Published: (2025-01-01)

Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis
by: Yong Wang, et al.
Published: (2025-05-01)

Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
by: Liang Wang, et al.
Published: (2025-07-01)

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016-07-01)

Comparative efficacy and safety of pegylated interferon-alpha monotherapy vs combination therapies with entecavir or tenofovir in chronic hepatitis B patients
by: Huiqing Liang, et al.
Published: (2025-05-01)

Need of Treatment Modification During Entecavir Therapy in Patients with Chronic Hepatitis B: Long-Term Follow-Up Results for 120 Months
by: Hae Rim Kim, et al.
Published: (2025-01-01)

A Sleeping Giant: Late HBV Reactivation After Rituximab-Based Chemotherapy Despite Correct Prophylaxis
by: Nowicka AA, et al.
Published: (2024-12-01)

Multiple drug-resistant HBV mutation may contribute to poor response of adefovir + entecavir in entecavir-resistant patients
by: Jinman Shao, et al.
Published: (2021-01-01)

Challenges in the Treatment of Acute Fulminant Hepatitis B: Case Report and Literature Review
by: Ali Alawieh, et al.
Published: (2014-08-01)

LIVER TRANSPLANTATION AND HBV INFECTION
by: O. I. Andreytseva, et al.
Published: (2009-06-01)

Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice
by: Yan Liu, et al.
Published: (2019-01-01)

Primary partial response with tenofovir monotherapy: two adults and one child
by: Habip Gedik
Published: (2022-05-01)

Entecavir: stability and drug-excipient compatibility
by: Ariadne Botto Fiorot, et al.
Published: (2025-01-01)

Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth
by: Ge Zhong, et al.
Published: (2025-02-01)

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA
by: Christine I. Wooddell, et al.
Published: (2024-12-01)

Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B
by: Qianqian Ma, et al.
Published: (2025-02-01)

Hepatitis B associated with severe COVID-19: a nationwide cohort study in Sweden
by: Frida Jakobsson, et al.
Published: (2025-04-01)

HBV-INFECTION DE NOVO AFTER ORTHOTOPIC LIVER TRANSPLANTATION: CLINICAL AND VIROLOGICAL CHARACTERISTICS, ASSESSMENT OF ANTIVIRUS THERAPY EFFECTIVENESS
by: O. I. Malomuzh, et al.
Published: (2012-09-01)

Musculoskeletal adverse events reported post-hepatitis B vaccination in the vaccine adverse event reporting system
by: Yiqing Sun, et al.
Published: (2025-05-01)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

Hepatoprotective and anti-inflammatory effects of entecavir or probiotics on Oxaliplatin-Induced Liver Injury in the rats.
by: Asem A. Askandar, et al.
Published: (2023-09-01)

<i>De novo</i> hepatitis B virus infection after liver transplantation
by: A. D. Nikogosova, et al.
Published: (2022-09-01)

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
by: Ling Ding, et al.
Published: (2025-12-01)

Variety of the hepatitis B virus genovariants in the military
by: Yu. V. Ostankova, et al.
Published: (2019-10-01)

Correlation between virological response and portal vein thrombosis in patients with chronic hepatitis B
by: Zhanghao Li, et al.
Published: (2025-07-01)

Booster immunity – diagnosis of chronic hepatitis B viral infection
by: Radka T Komitova, et al.
Published: (2019-03-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

Features of occult hepatitis B diagnostics in cancer patients
by: E. A. Shevyakova, et al.
Published: (2025-03-01)

Comparison of HBV-DNA Levels with Biochemical and Microbiological Parameters for Chronic Hepatitis Evaluation, Bursa, Turkey
by: Sanem Karadag Gecgel
Published: (2021-03-01)

Seroprevalence of hepatitis B among the general population in Shandong Province, Eastern China, an update 30 years after the implementation of the neonatal vaccination program
by: Bingyu Yan, et al.
Published: (2024-12-01)

Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China
by: Peipei Wang, et al.
Published: (2025-03-01)

Hepatitis B: Assessment of Knowledge, Attitude, and Practice among the Graduating Dental Students of Odisha: A Web-Based Survey
by: Shubham Kashyap, et al.
Published: (2024-12-01)

HBV - infection in children with perinatal infection. Clinical report of familial hepatitis B
by: I. V. Shilova, et al.
Published: (2021-10-01)

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?
by: Giovana Paula Angelice, et al.
Published: (2024-10-01)

Evaluation of a recombinant DNA hepatitis B vaccine in a vaccinated Nigerian population
by: Moses P. Adoga, et al.
Published: (2010-08-01)